Believe Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: a GLP-1 microdose protocol offered alongside a published peptide catalog
Price is where Believe Health scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Believe Health’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
Believe Health is a physician-led telehealth brand offering compounded semaglutide, tirzepatide, a GLP-1 microdose protocol and a daily oral GLP-1 alongside a peptide catalog. Its peptides page lists starting prices: semaglutide injection from $119 a month, and tirzepatide injection, the microdose and the oral option from $149 a month. Full plan terms appear only after an eligibility intake, and plans include medication, physician review, coaching and a dietitian visit.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Believe Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $119/mo (starting dose) · no insurance needed
Believe Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $119/mo (starting dose)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored Believe Health
Each dimension is scored algorithmically from Believe Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $119/mo (starting dose), Believe Health runs about 34% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.0/10Believe Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
5.9/10Online intake and platform experience (consult included in the price); 1 platform feature disclosed.
Trust & Safety15%
6.1/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
4.9/10Believe Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.0/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Believe Health review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $119–$149/mo across 4 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Believe Health
We walked Believe Health’s public signup flow in August 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Open a treatment page such as /treatments/semaglutide, which describes the protocol but shows no price.
- 2Select the call to action, which leads to /eligibility.
- 3Complete the eligibility flow; pricing is presented after that rather than before.
- Treatment pages show no GLP-1 price; the peptides page lists starting prices (semaglutide from $119/mo; tirzepatide, microdose and oral from $149/mo).
- On October 30, 2026 the peptides page listed those GLP-1 starting prices next to tesamorelin, sermorelin, NAD+ and PT-141.
- The homepage advertises $0 If Not Approved, so the eligibility check itself carries no charge.
- Compounded in the USA is stated on the homepage; no specific pharmacy is named.
- The eligibility form opens without creating an account.
GLP-1 medications Believe Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Listed 'from $119/mo' on the peptides page. Plan terms behind the starting price appear after the eligibility intake.
Listed 'from $149/mo' on the peptides page. Plan terms behind the starting price appear after the eligibility intake.
Listed 'from $149/mo' on the peptides page as a lower-dose protocol. It starts above the standard semaglutide price, and no molecule is named.
Listed 'from $149/mo' on the peptides page as a daily oral option. No molecule is named and there is no published bioavailability data for this route.
Ready to get started?
Plans and promotions change often, so check Believe Health's current pricing and active discounts before you decide.
What we like
- Offers semaglutide, tirzepatide and a dedicated GLP-1 microdose protocol, so low-dose starters are served explicitly
- States a $0 charge if you are not approved, so the eligibility check carries no cost
- Flat pricing at every dosage, with medication, physician review, care coaching and a dietitian visit included in one monthly figure
- Compounded in the USA is stated on the homepage
Watch-outs
- Treatment pages show no prices; starting prices appear only on the peptides page, and full plan terms only after an eligibility intake
- The microdose plan starts higher than standard semaglutide ($149 versus $119), which is the opposite of what most buyers assume
- States served are not enumerated anywhere on the site
- No dispensing pharmacy named and no LegitScript badge displayed
- Two of the four plans name no molecule at all and are sold only as GLP-1 Microdose and GLP-1 Oral
Is Believe Health worth it?
Believe Health's whole pitch comes down to this: a GLP-1 microdose protocol offered alongside a published peptide catalog. It runs $119/month (starting dose) at every dose. That is a qualified figure, not a plain month-to-month price, so we don't rank it against the category median; the cost section below says what it covers. Its standout is a needle-free oral option for people who would rather not inject.
How much Believe Health costs
Compounded semaglutide runs $119/month (starting dose), compounded tirzepatide runs $149/month (starting dose), and compounded glp-1 oral, daily, starting price, molecule not named runs $149/month (starting dose).
Because Believe Health's headline figure is a starting dose, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Believe Health with the month-to-month prices of the alternatives below instead.
Brightmeds (about $129/month) is one of the closest alternatives to weigh Believe Health against.
Medications: what Believe Health prescribes
Believe Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Believe Health's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Believe Health is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Believe Health is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see Believe Health against the wider field, use the full list of semaglutide providers we rank; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Price is where Believe Health scores best in our breakdown.
Ready to start with Believe Health?
From $119/mo (starting dose). See current pricing and start your free consultation.
Believe Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Believe Health vs…
Believe Health scores6.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Believe Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Believe Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Believe Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Believe Health's current pricing
Plans from $119/mo (starting dose). Start your free consultation to check eligibility and today's price.